GH receptor, a member of the class I cytokine receptor family, is an amino acid dimeric receptor with an extracellular domain (ECD), a single-pass transmembrane domain (IMD), and a cytoplasmic intracellular domain (ICD) ( GHR is widely expressed in GH target cells, which can combine with GH to activate diverse signal cascades, including mitogenic signaling through Janus kinase (JAKs) signal transducers and activators of transcription (STATs) (Vanderkuur et al., 1997), phosphoinositide-3-kinase (PI3K)/Protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) pathways (Hayashi and Proud, 2007) and phospholipase C (PLC)/Protein kinase C (PKC) ( GHR will further disrupt the normal development of the organism and lead to dwarfism phenotype in a wide array of species (Lin et al., 2018)
Banerjee, et al., observed in a rodent study that morphineinduced disruption of the GM triggers an inflammatory response initiated by IL-17 and sustained by IL-6 [120]
The peptide was originally characterized by the Sikiric group at the University of Zagreb School of Medicine and has been investigated for over two decades in preclinical research models for its effects on tissue regeneration, angiogenesis, fibroblast migration, and cellular signaling across tendon, ligament, muscle, gastrointestinal, and vascular tissues
Specific dosing parameters vary significantly between studies and animal models researchers should reference the primary literature for protocol design
